Roles of PFKFB3 in cancer

Linlin Shi(Sir Run Run Shaw Hospital), Hongming Pan(Sir Run Run Shaw Hospital), Zhen Liu(Sir Run Run Shaw Hospital), Jiansheng Xie(Sir Run Run Shaw Hospital), Weidong Han(Sir Run Run Shaw Hospital)
Signal Transduction and Targeted Therapy
November 24, 2017
Cited by 302Open Access
Full Text

Abstract

The understanding of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFK-2/FBPase 3, PFKFB3) has advanced considerably since its initial identification in human macrophages in the mid-1990s. As a vital regulator of glycolysis, accumulating studies have suggested that PFKFB3 is associated with many aspects of cancer, including carcinogenesis, cancer cell proliferation, vessel aggressiveness, drug resistance and tumor microenvironment. In this review, we summarize current knowledge of PFKFB3 regulation by several signal pathways and its function in cancer development in different cell types in cancer tissues. Ubiquitous PFKFB3 has emerged as a potential target for anti-neoplastic therapy.


Related Papers

No related papers found

Powered by citation graph analysis